EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids

Wunan Mi iD, Gilles S van Tienderen, Shaojun Shi, Amy Broeders, Kathryn Monfils, Henk P Roest, Luc J W van der Laan iD, Monique M A Verstegen iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Wunan Mi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Erasmus MC Transplant Institute, University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Organoids, Drug Resistance, Neoplasm, Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cost Action Precision-BTC-Network, Dutch Society for Gastroenterology, Dutch Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma (CCA) is a rare but devastating liver cancer which is commonly diagnosed at a late stage and often resistant to chemotherapy. Bcl‐2 family members, which control apoptotic cell death, are known to be involved in the chemoresistance of some cancer types. This study investigated the role of Bcl‐2 family members in the chemoresistance of cholangiocarcinoma organoids (CCAOs) in both undifferentiated and matured branching phenotypes (BRCCAOs). Patient‐derived CCAOs and BRCCAOs were cultured to assess chemoresistance to an FDA‐approved anticancer drug panel by testing cell viability using ATP quantification and apoptotic cell death by cleaved caspase 3 staining. More specifically, sensitivity to the first‐line drug gemcitabine was tested in combination with Bcl‐2 family inhibitors or activators. We found that in gemcitabine‐resistant CCAOs, inhibition of Bcl‐xl could overcome gemcitabine resistance and induce apoptotic cell death. Although inhibition of Mcl‐1 or activation of Bax induced spontaneous cell death, this could not overcome gemcitabine resistance. The BRCCAOs, which mimic tumor architecture better than CCAOs, show broader chemoresistance to anticancer drugs. Of note, in the resistant BRCCAOs, Bcl‐xl inhibition could restore gemcitabine sensitivity. In conclusion, this study shows that targeting Bcl‐xl can overcome chemoresistance to gemcitabine in CCA organoids. CCAOs and BRCCAOs provide good preclinical models for testing new drug combinations and assessing personalized therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaOrganoidsDrug Resistance, NeoplasmBile Duct NeoplasmsProto-Oncogene Proteins c-bcl-2HumansDeoxycytidineGemcitabineApoptosisbcl-X ProteinMyeloid Cell Leukemia Sequence 1 ProteinCell Line, Tumorbcl-2-Associated X Protein

Stichwörter der Autor:innen

Bcl‐2chemoresistancecholangiocarcinomagemcitabineorganoids

Substanzen

DeoxycytidineGemcitabineProto-Oncogene Proteins c-bcl-2bcl-X ProteinMyeloid Cell Leukemia Sequence 1 ProteinBCL2L1 protein, humanBCL2 protein, humanbcl-2-Associated X ProteinMCL1 protein, human

Autor:innen und Institutionen

  • Department of Surgery, Erasmus MC Transplant Institute, University Medical Center, Rotterdam, The Netherlands.
  • Department of Organ Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

ORCID-Profile: Wunan Mi, Luc J W van der Laan, Monique M A Verstegen

Förderung

  • Cost Action Precision-BTC-Network
  • Dutch Society for Gastroenterology
  • Dutch Cancer Society
  • Erasmus MC Human Disease Model Award 2018
  • Dutch Research Council
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Mi, W., van Tienderen, G. S., Shi, S., Broeders, A., Monfils, K., Roest, H. P., van der Laan, L. J. W., & Verstegen, M. M. A. (2025). Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids. International Journal of Cancer. https://doi.org/10.1002/ijc.35483

Vancouver

Mi W, van Tienderen GS, Shi S, Broeders A, Monfils K, Roest HP, et al. Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids. International Journal of Cancer. 2025. doi:10.1002/ijc.35483

BibTeX
@article{Mi2025,
  author = {Mi, Wunan and van Tienderen, Gilles S and Shi, Shaojun and Broeders, Amy and Monfils, Kathryn and Roest, Henk P and van der Laan, Luc J W and Verstegen, Monique M A},
  title = {Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35483}
}
Kostenlos starten →